Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies beyond Female Breast and Ovarian Cancers

Sari Lieberman, Hadar Goldvaser, Ephrat Levy-Lahad*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1590-1594
Number of pages5
JournalJournal of Clinical Oncology
Issue number14
StatePublished - 10 May 2022
Externally publishedYes

Cite this